Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study

ConclusionsThe data from the study adds to the existing safety database of Nasovac-S.RegistryClinical Trials Registry of India (CTRI/2015/08/006074).
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research